TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33092707

Group type: EXPERIMENTAL
Intervention: TMVr with the MitraClip plus guideline-directed medical therapy (GDMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 0
Study: 34481803

Group type: EXPERIMENTAL
Intervention: Nedosiran (1.5, 3.0, or 6.0 mg/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nedosiran (0.3, 1.5, 3.0, 6.0, then 12.0 mg/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 34688281

Group type: EXPERIMENTAL
Intervention: Program intervention (PA4E1)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 33191341

Group type: EXPERIMENTAL
Intervention: Lowest DKK3 tertile
Number of subjects: 550

Group type: COMPARATOR
Intervention: DKK3 tertiles 1-3
Number of subjects: 550

Group type: COMPARATOR
Intervention: DKK3 levels
Number of subjects: 550
Study: 34362453

Group type: EXPERIMENTAL
Intervention: Intrathecal injection of umbilical cord tissue mesenchymal stem cells (UCT‐MSC), single-dose (2 × 10^7) cells.
Number of subjects: 72
Study: 33000588

Group type: EXPERIMENTAL
Intervention: Xiaoyin Jiedu (XYJD) granules
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 32063367

Group type: EXPERIMENTAL
Intervention: Abbreviated perioperative care bundle (APCB)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard perioperative care
Number of subjects: 74
Study: 36402988

Group type: EXPERIMENTAL
Intervention: CVD clinical decision support (CDS) system
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 314
Study: 34768600

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.8 mg) and Bupivacaine (5%) with articaine–epinephrine (40/0.005 mg/mL)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Articaine–epinephrine (40/0.005 mg/mL)
Number of subjects: 184
Study: 35288059

Group type: EXPERIMENTAL
Intervention: Emotion-focused behavioral intervention
Number of subjects: 216

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 216
Study: 34481524

Group type: EXPERIMENTAL
Intervention: 1 g tranexamic acid (TXA) administered immediately after induction of general anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: No TXA (control group)
Number of subjects: 40
Study: 34332050

Group type: EXPERIMENTAL
Intervention: Intramedullary unicortical button
Number of subjects: 20

Group type: COMPARATOR
Intervention: All-suture anchors
Number of subjects: 20
Study: 32305787

Group type: COMPARATOR
Intervention: General anesthesia alone (control group)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Very-low-dose spinal analgesia (levobupivacaine 3.75 mg; sufentanil 2.5 μg)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Low-dose spinal analgesia (levobupivacaine 7.5 mg; sufentanil 2.5 μg)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Very-low-dose spinal analgesia
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Low-dose spinal analgesia
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 99
Study: 36181080

Group type: EXPERIMENTAL
Intervention: Complete laparoscopic surgery with modified triangular anastomosis technique
Number of subjects: 86

Group type: COMPARATOR
Intervention: Laparoscopic-assisted small incision colon reconstruction surgery
Number of subjects: 86
Study: 34481517

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg (with loading dose)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg (without loading dose)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 555
Study: 32446674

Group type: EXPERIMENTAL
Intervention: Established Status Epilepticus Treatment Trial
Number of subjects: 317
Study: 35206521

Group type: EXPERIMENTAL
Intervention: Peer-delivered stop-smoking programme (group support, combination nicotine replacement therapy (NRT), and tailored individual support)
Number of subjects: 176
Study: 34151822

Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Insole application
Number of subjects: 52
Study: 32667053

Group type: EXPERIMENTAL
Intervention: Intervention group (non-breastfeeding mothers)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Control group (non-breastfeeding mothers)
Number of subjects: 449
Study: 35393757

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: High sensitive faecal immunochemical test (FIT)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Unsubscribing from screening
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Logistical concerns about the screening procedure
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Confirmation of participation
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: FIT screening difficulties or in need of a new FIT test
Number of subjects: 2000
Study: 32071149

Group type: EXPERIMENTAL
Intervention: Quercetin at 500, 1000 or 2000 mg/day for 1 week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34580826

Group type: EXPERIMENTAL
Intervention: Supervised, facility-based aerobic exercise intervention (n=73)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention (n=69)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Wait-listed control group (n=71)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Supervised, facility-based aerobic exercise intervention (n=73) among women with a family history of breast cancer
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention (n=69) among women with a family history of breast cancer
Number of subjects: 213
Study: 34162791

Group type: COMPARATOR
Intervention: Control group (not randomized to any intervention)
Number of subjects: 43
Study: 35345792

Group type: EXPERIMENTAL
Intervention: Laparoscopic trans-abdominal pre-peritoneal repair (TAPP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open Lichtenstein repair
Number of subjects: 100
Study: 32233245

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of PRP (2 ml) and extra-articular injection of PRP (2 ml), once a week for three times.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intra-articular injection of sodium hyaluronate (20 mg) and extra-articular injection of analgesic drug (2 ml for one point), once a week for three times.
Number of subjects: 48
Study: 33387398

Group type: EXPERIMENTAL
Intervention: Silicone gel containing onion extract and aloe vera (SGOA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Silicone gel sheets (SGS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 32531968

Group type: EXPERIMENTAL
Intervention: Group with slow‐paced music at a tempo of 60 BPM (GS)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Group with fast‐paced music at a tempo of 105 BPM (GF)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Group control without music (GC)
Number of subjects: 56
Study: 35697424

Group type: EXPERIMENTAL
Intervention: TranS‐C plus usual care (TranS‐C+UC)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care followed by delayed treatment with TranS‐C (UC‐DT)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: TranS‐C skills
Number of subjects: 53
Study: 33847862

Group type: EXPERIMENTAL
Intervention: 3 months DAPT
Number of subjects: 1500

Group type: COMPARATOR
Intervention: 12 months DAPT
Number of subjects: 1500
Study: 35924333

Group type: EXPERIMENTAL
Intervention: Jogging Device (JD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 24
Study: 33857980

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE) in the midesophageal 4-chamber (ME 4Ch) view
Number of subjects: 25

Group type: COMPARATOR
Intervention: Transthoracic echocardiography (TTE) in the apical 4-chamber (AP 4Ch) view
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE) in the deep transgastric view (DTG)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Speckle tracking-based strain rate in the ME 4Ch view
Number of subjects: 25

Group type: COMPARATOR
Intervention: Speckle tracking-based strain rate in the AP 4Ch view
Number of subjects: 25
Study: 33219673

Group type: EXPERIMENTAL
Intervention: Intensive weight-loss lifestyle intervention
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 228
Study: 32855972

Group type: EXPERIMENTAL
Intervention: TXA (tranexamic acid)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 40
Study: 33566146

Group type: EXPERIMENTAL
Intervention: ACLR with LET
Number of subjects: 20

Group type: COMPARATOR
Intervention: ACLR
Number of subjects: 20
Study: 33837098

Group type: EXPERIMENTAL
Intervention: Optimised respiratory care home-based (ORC) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional respiratory care (CRC) group
Number of subjects: 0
Study: 36150864

Group type: EXPERIMENTAL
Intervention: Mobile phone-based psychological intervention (3 modules: support, education, and reflection)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conventional face-to-face intervention and advice from clinical educators
Number of subjects: 114
Study: 33877323

Group type: EXPERIMENTAL
Intervention: Liquid micellar preparation (1000 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dried colloidal suspension (300 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard turmeric extract (1500 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Piperine-curcuminoid combination (1515 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Phytosome formulation (1000 mg)
Number of subjects: 30
Study: 34782419

Group type: EXPERIMENTAL
Intervention: IV thrombolysis with alteplase at 0.9 mg/kg body weight
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Presence of CMBs
Number of subjects: 459
Study: 34571144

Group type: EXPERIMENTAL
Intervention: Music Group: patients hearing instrumental music through a headset during the entire procedure
Number of subjects: 107

Group type: COMPARATOR
Intervention: No Music Group: patients wearing headphones without music
Number of subjects: 107
Study: 34106300

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (SGLT2 inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sotagliflozin (SGLT2 inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finerenon (mineralocorticoid receptor antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MitraClip® implantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kidney replacement therapy initiation timing
Number of subjects: 0
Study: 33727902

Group type: EXPERIMENTAL
Intervention: Basic activities of daily living
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Memory
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Trial Making Test (B-A)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Motoricity index
Number of subjects: 90
Study: 36343424

Group type: EXPERIMENTAL
Intervention: High energy (80 mJ) and high density (12.6%) - Group A (HeHd)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High energy (80 mJ) and low density (8%) - Group B (HeLd)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low energy (60 mJ) and low density (8%) - Group C (LeLd)
Number of subjects: 48
Study: 35533724

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 3799
Study: 34320508

Group type: EXPERIMENTAL
Intervention: Primary tumor resection (PTR) in right-sided mCC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary tumor resection (PTR) in left-sided mCC
Number of subjects: 0
Study: 32106274

Group type: EXPERIMENTAL
Intervention: Omega-3 polyunsaturated fatty acids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35221199

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Spontaneous breathing (SB)
Number of subjects: 15
Study: 32102617

Group type: EXPERIMENTAL
Intervention: Top quintile fish intake
Number of subjects: 26034

Group type: EXPERIMENTAL
Intervention: Fish intake
Number of subjects: 26034

Group type: EXPERIMENTAL
Intervention: α-linolenic acid intake
Number of subjects: 26034

Group type: EXPERIMENTAL
Intervention: Total n-3, docosahexaenoic acid, and α-linolenic acid intake
Number of subjects: 26034

Group type: EXPERIMENTAL
Intervention: High eicosapentaenoic acid intake
Number of subjects: 26034
Study: 35140309

Group type: EXPERIMENTAL
Intervention: Oropharyngeal mother's milk administration for 14 days
Number of subjects: 130

Group type: COMPARATOR
Intervention: Oropharyngeal 0.9% normal saline administration
Number of subjects: 130
Study: 32488680

Group type: EXPERIMENTAL
Intervention: CePROP = 3.6 μg⋅ml−1 and CeREMI = 4 ng⋅ml−1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CePROP
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CeREMI
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Haemodynamic and arousal responses evoked by laryngoscopy
Number of subjects: 80
Study: 32276630

Group type: EXPERIMENTAL
Intervention: Ketogenic Diet (KD)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-Ketogenic Diet (NKD)
Number of subjects: 21
Study: 35751549

Group type: EXPERIMENTAL
Intervention: Dry cupping therapy (DCT) for 8 minutes daily for 15 days (Group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dry cupping therapy (DCT) for 10 minutes daily for 15 days (Group B)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dry cupping therapy (DCT) for 12 minutes daily for 15 days (Group C)
Number of subjects: 45
Study: 33445205

Group type: EXPERIMENTAL
Intervention: GPB 1% cream
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 32125555

Group type: EXPERIMENTAL
Intervention: Conventional therapy supplemented with 750 mg of S. boulardii CNCM I-745 daily for 2 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 63
Study: 35948848

Group type: EXPERIMENTAL
Intervention: Supervised personal training (PT)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Supervised group-based (GROUP) program
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Home-based, smartphone-assisted exercise (HOME) intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: Baseline predictors (Aesthetics domain of NEWS questionnaire)
Number of subjects: 37
Study: 32967000

Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic dose)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study: 32807106

Group type: EXPERIMENTAL
Intervention: Flexible fibreoptic intubation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional intubation
Number of subjects: 30
Study: 35245668

Group type: EXPERIMENTAL
Intervention: 3D echocardiography
Number of subjects: 748
Study: 32867699

Group type: EXPERIMENTAL
Intervention: 99mTc-sodium phytate (99mTc-SP)
Number of subjects: 31

Group type: COMPARATOR
Intervention: 99mTc-sulfur colloid (99mTc-SC)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both radiotracers
Number of subjects: 31
Study: 35985959

Group type: EXPERIMENTAL
Intervention: CyBorD-DARA (Daratumumab with cyclophosphamide, bortezomib, and dexamethasone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CyBorD-DARA
Number of subjects: 0
Study: 33082219

Group type: EXPERIMENTAL
Intervention: Closed-loop oxygen control
Number of subjects: 42

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fixed concentration of 28% oxygen
Number of subjects: 42

Group type: COMPARATOR
Intervention: 28% oxygen
Number of subjects: 42
Study: 34740318

Group type: EXPERIMENTAL
Intervention: BPS + NFRT
Number of subjects: 114

Group type: COMPARATOR
Intervention: BPS
Number of subjects: 114
Study: 35397179

Group type: EXPERIMENTAL
Intervention: Conventional education module (Group I) using verbal explanation supported by photographs.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Customized VR based educational video (Group II).
Number of subjects: 20
Study: 34390556

Group type: EXPERIMENTAL
Intervention: 8 weekly stress management sessions
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 144
Study: 33119680

Group type: EXPERIMENTAL
Intervention: Prescribed medications during the previous year
Number of subjects: 326450

Group type: EXPERIMENTAL
Intervention: Locally acting antacids
Number of subjects: 326450

Group type: EXPERIMENTAL
Intervention: Propulsives
Number of subjects: 326450

Group type: EXPERIMENTAL
Intervention: Vitamin A and D
Number of subjects: 326450

Group type: EXPERIMENTAL
Intervention: Loop diuretics (e.g., furosemide)
Number of subjects: 326450

Group type: EXPERIMENTAL
Intervention: Thiazide diuretics
Number of subjects: 326450

Group type: EXPERIMENTAL
Intervention: Major cardiovascular drug classes
Number of subjects: 326450
Study: 35254765

Group type: EXPERIMENTAL
Intervention: CAL/BDP PAD-cream
Number of subjects: 1271

Group type: COMPARATOR
Intervention: CAL/BDP suspension/gel
Number of subjects: 1271
Study: 33465838

Group type: COMPARATOR
Intervention: Partial range of motion (ROM) training (9º)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Full range of motion (ROM) training
Number of subjects: 15
Study: 32639688

Group type: EXPERIMENTAL
Intervention: Cluster needling of scalp acupuncture on top of drug treatment
Number of subjects: 56

Group type: COMPARATOR
Intervention: Drug treatment only
Number of subjects: 56
Study: 35466438

Group type: EXPERIMENTAL
Intervention: Acalabrutinib suspension (Acala-NG) administered via NG tube
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acalabrutinib suspension (Acala-NG) with PPI (rabeprazole)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral acalabrutinib capsule administered with water
Number of subjects: 0
Study: 33653620

Group type: EXPERIMENTAL
Intervention: SPH3127 (25 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (50 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (100 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (200 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (400 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (800 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (100 mg, MAD)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (200 mg, MAD)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (400 mg, MAD)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (100 mg, steady state)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (200 mg, steady state)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (400 mg, steady state)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (SAD >100 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SPH3127 (MADs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32813290

Group type: EXPERIMENTAL
Intervention: adaptive dual n-back task
Number of subjects: 44

Group type: COMPARATOR
Intervention: active control task
Number of subjects: 44
Study: 33464969

Group type: EXPERIMENTAL
Intervention: Death narratives
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Foreshadowed death narratives
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Survivor narratives
Number of subjects: 1010
Study: 33689238

Group type: EXPERIMENTAL
Intervention: Vaginal 25mcg misoprostol
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Vaginal 4000mg evening primrose oil (EPO)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Double-balloon catheter
Number of subjects: 90
Study: 35253453

Group type: EXPERIMENTAL
Intervention: Text message intervention to improve sexual health outcomes
Number of subjects: 6250

Group type: EXPERIMENTAL
Intervention: Recruitment strategies aimed at engaging and motivating recruiting staff
Number of subjects: 6250
Study: 32646041

Group type: EXPERIMENTAL
Intervention: Synchronized neuromuscular electrical stimulation (NMES) with chewing exercises
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chewing exercises alone (Control)
Number of subjects: 40
Study: 35504645

Group type: EXPERIMENTAL
Intervention: Very early invasive coronary angiography (ICA) ± revascularisation
Number of subjects: 425

Group type: COMPARATOR
Intervention: Standard of care timing of ICA ± revascularisation
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Cardiac magnetic resonance (CMR) substudy
Number of subjects: 425
Study: 34940843

Group type: EXPERIMENTAL
Intervention: Trial participants
Number of subjects: 7091179
Study: 35101276

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 139

Group type: COMPARATOR
Intervention: No mechanical bowel preparation (no-MBP)
Number of subjects: 139
Study: 34323542

Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT) intervention
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control condition (episodic thinking)
Number of subjects: 89
Study: 35178208

Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg BD for 3 days)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 33465285

Group type: EXPERIMENTAL
Intervention: ELX-02 at 5.0 mg/kg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 33714510

Group type: EXPERIMENTAL
Intervention: Vibrating platform at a frequency of 30 Hz
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isometric abdominal exercises without vibration
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both exercises (with and without vibration)
Number of subjects: 30
Study: 32889781

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High hormone (HH) phase
Number of subjects: 26
Study: 35152909

Group type: EXPERIMENTAL
Intervention: Conservative oxygenation targets (PaO2 55-80 mmHg)
Number of subjects: 1512

Group type: COMPARATOR
Intervention: Conventional oxygenation targets (PaO2 110-150 mmHg)
Number of subjects: 1512